Extra-Virgin Olive Oil Reduces Glycemic Response to a High–Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial Featured.

Slides:



Advertisements
Similar presentations
Reductions in Regimen Distress Are Associated With Improved Management and Glycemic Control Over Time Featured Article: Danielle Hessler, Lawrence Fisher,
Advertisements

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Previous research suggests LGI meals can curtail glycemic response at the beginning of exercise and sustain substrate supply near the end of extended exercise.
Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin Featured Article: Beverley Balkau, Philip D. Home, Maya Vincent,
New Insulin Glargine 300 Units∙mL2-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine.
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes Featured Article: Michaela Diamant, Michael A.
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia.
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial Featured Article: Ravi Retnakaran, Caroline K.
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections.
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes.
The Disease: Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin.
1 NEPHRO – 2014 VALENCIA, SPAIN JUNE 25-28, 2014 NEPHRO – 2014 VALENCIA, SPAIN JUNE 25-28, 2014 [1]
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial Featured Article: J. Graham Thomas, Tricia M.
Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive Featured Article: Carmel.
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
Diabetes Technology Update
Effect of Lowering the Glycemic Load With Canola Oil on Glycemic Control and Cardiovascular Risk Factors: A Randomized Controlled Trial Featured Article:
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A double-tracer study.
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas Featured Article: Boris P. Kovatchev, Eric.
Metabolic Effects of Bariatric Surgery
Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes.
Jason Atkinson Health & Science Education Mercer University.
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free- Living, Randomized Clinical Trial Featured Article: Roman Hovorka,
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes Featured.
IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention The POUNDS LOST trial Featured Article: Qibin.
Moderate Amounts of Fructose Consumption Impair Insulin Sensitivity in Healthy Young Men: A Randomized Controlled Trial Featured Article: Isabelle Aeberli,
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients Featured Article: Hao Hu, Wenjun Sun, Shuqin Yu, Xiafei Hong, Weiyun.
Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea A.
Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2008 年5月1日 8:20-8:50 B 棟8階 カンファレンス室.
Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes:
Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients Featured Article: Takehiro Okabayashi, Yasuo Shima,Tatsuaki Sumiyoshi,
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Siri, what should I eat? Zeevi et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 2015;163(5): Vanessa Ha.
Featured Article: Wayne H.-H. Sheu, Ira Gantz, Menghui Chen, Shailaja Suryawanshi, Arpana Mirza, Barry J. Goldstein, Keith D. Kaufman, and Samuel S. Engel.
Daniel A. Baur, Fernanda S. Vargas, Jordan A. Garvey, Christopher W. Bach, and Michael J Ormsbee, FACSM Institute of Sports Sciences and Medicine, Department.
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine A 24-Week,
Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes Featured Article: Jennifer.
CAN WE IMPROVE POSTPRANDIAL GLUCOSE CONTROL WITH FAST-ACTING INSULINS?
Key publication slides
New Patient-Friendly Options for Managing Insulin Dosing
Utilizing New Technologies and Insulins for a Tighter Grip on PPG
Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review  Anne L Harrison, Nora Shields, Nicholas.
Volume 70, Issue 8, Pages (October 2006)
Faster-Acting Insulins
(A) Fasting serum glucose (mg/dL), (B) fasting serum insulin (μU/mL), (C) plasma glycated albumin (GA; %) and (D) plasma fructosamine (μmol/L) measured.
Flowchart of literature search for the effect of fructose on glycemic end points (fasting glucose, fasting insulin, and glycated blood proteins [HbA1c.
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Patient flow chart: the final prospective study population consisted of 521 individuals, 113 on basal insulin and 408 on OADs. *Plausibility: height (130–230 cm),
Comparison of triglycerides AUC 480’ between IGT+reduced FPIS group, IGT+preserved FPIS group, and IGT+reduced FPIS+reduced FPIS and FPIS restitution with.
A: PPG increment at week 26 for mealtime faster aspart versus IAsp.
Mean ± SEM concentration of insulin in plasma and CSF and glucose in plasma 30 min after the intraperitoneal administration of DET or NPH insulin at different.
Forest plot of randomised controlled trials investigating the effects of pasta in the context of low-GI dietary patterns on body weight (kg). n=2448. Forest.
Plot of the pooled effect estimates from randomised controlled trials investigating the effects of pasta in the context of low-GI dietary patterns on global.
Effect of high-fat (breeder food) diet and 16 h of fasting on triglyceride levels and leptin transport. Effect of high-fat (breeder food) diet and 16 h.
Insulin sensitivity in athletes and sedentary normal-weight and obese, young, and old individuals. Insulin sensitivity in athletes and sedentary normal-weight.
Metabolic effects of VSG in GLP-1r KO mice.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.
Meal control achieved in the five meals of the study (the first dinner was handled in open-loop mode, and all other meals were handled by closed-loop).
Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.
Distribution of daily frequency of BGM
Postprandial glucose, insulin and glucagon-like peptide-1 (GLP-1) levels following carbohydrate-first (CF), carbohydrate-last (CL) and sandwich (S) meal.
Postoperative blood glucose levels and total insulin requirement.
A: Glucose levels during basal-bolus and SSI treatment.
Presentation transcript:

Extra-Virgin Olive Oil Reduces Glycemic Response to a High–Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial Featured Article: Lutgarda Bozzetto, Antonio Alderisio, Marisa Giorgini, Francesca Barone, Angela Giacco, Gabriele Riccardi, Angela A. Rivellese, and Giovanni Annuzzi Diabetes Care Volume 39: 518–524 April 2016

STUDY OBJECTIVE To evaluate whether fat quality, in the context of meals with high– (HGI) or low–glycemic index (LGI), influences postprandial blood glucose (PPG) response in patients with type 1 diabetes Bozzetto L. et al. Diabetes Care 2016;39:518–524

STUDY DESIGN AND METHODS Thirteen patients with type 1 diabetes on insulin pump consumed two series (HGI or LGI) of meals with the same carbohydrate quantity while differing for amount and quality of fat: 1. low in fat (“low fat”), 2. high in saturated fat (butter), or 3. high in monounsaturated fat (extra-virgin olive oil) (EVOO). Premeal insulin doses were based on insulin–to–glycemic load ratios. Continuous glucose monitoring was performed and 6-h PPG evaluated. Bozzetto L. et al. Diabetes Care 2016;39:518–524

RESULTS PPG was significantly different between HGI and LGI meals, being significantly higher during the first 3 h after the HGI meals with a later tendency to an opposite pattern. In the context of HGI meals, PPG was significantly lower after EVOO than after low fat or butter, with a marked difference in the 0- to 3-h glucose incremental area under the curve between EVOO (mean ± SD 198 ± 274 mmol/L × 180 min) and either low fat (416 ± 329) or butter (398 ± 355). No significant differences were observed in PPG between the three LGI meals. Bozzetto L. et al. Diabetes Care 2016;39:518–524

CONCLUSIONS An optimal prandial insulin administration would require considering, in addition to the quantity of carbohydrates, the quality of both carbohydrate and fat. Bozzetto L. et al. Diabetes Care 2016;39:518–524